Granules Pharmaceuticals, Inc. is a pharmaceutical company based out of 3701 Concorde Parkway, Chantilly, Virginia, United States. Building on global R&D innovation and manufacturing strength, Granules Pharmaceuticals Inc. (GPI) is a U.S.-based pharmaceutical company dedicated to delivering high-quality, affordable medicines. Our state-of-the-art, US FDA and DEA-approved facility brings together advanced research, development, and manufacturing capabilities to support a growing portfolio of generic, controlled substance, and over-the-counter products. At Granules, we believe that consistency at the smallest level leads to confidence at the largest. Our expertise in complex oral solid dosage forms, including tablets, capsules, powders, and oral solutions, reflects a precise and disciplined approach to developing medicines that meet rigorous U.S. regulatory standards. Today, Granules is a top 20 generic pharmaceutical company by volume in the United States and a trusted OTC partner to leading retailers. Across every product we develop and manufacture, we remain focused on delivering consistent quality, reliable supply, and affordability for the patients and communities we serve.